Correlation Between NYSE Composite and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Edgewise Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Edgewise Therapeutics.
Diversification Opportunities for NYSE Composite and Edgewise Therapeutics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between NYSE and Edgewise is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Edgewise Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 33.96 times less return on investment than Edgewise Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 19.22 times less risky than Edgewise Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 1,933 in Edgewise Therapeutics on June 24, 2024 and sell it today you would earn a total of 895.00 from holding Edgewise Therapeutics or generate 46.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Edgewise Therapeutics
Performance |
Timeline |
NYSE Composite and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Edgewise Therapeutics
Pair trading matchups for Edgewise Therapeutics
Pair Trading with NYSE Composite and Edgewise Therapeutics
The main advantage of trading using opposite NYSE Composite and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.NYSE Composite vs. Compania Cervecerias Unidas | NYSE Composite vs. Tootsie Roll Industries | NYSE Composite vs. Ispire Technology Common | NYSE Composite vs. NH Foods Ltd |
Edgewise Therapeutics vs. HCW Biologics | Edgewise Therapeutics vs. RenovoRx | Edgewise Therapeutics vs. Scpharmaceuticals | Edgewise Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |